← Open Payments lookup

KIMBERLY DRAKE: Open Payments

NPI 1174580245 · MARRERO, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,417 in 90 payments from 16 companies in 2025. Trend: 2023 $640 · 2024 $1,342 · 2025 $1,417

Food & beverage: $1,417
CompanyPaymentsAmount
Takeda Pharmaceuticals U.S.A., Inc.20$217
Janssen Biotech, Inc.15$217
Salix Pharmaceuticals, a division of Bausch Health US, LLC12$183
Ardelyx, Inc.8$169
Celltrion USA Inc.6$110
Gilead Sciences, Inc.3$77
Ipsen Biopharmaceuticals, Inc3$71
Regeneron Healthcare Solutions, Inc.2$61
Aimmune Therapeutics, Inc.3$60
ABBVIE INC.3$57

Products named: TREMFYA, ENTYVIO, XIFAXAN, IBSRELA, VEGZELMA, IQIRVO, DUPIXENT, ZENPEP.

Industry payments across LA — which companies pay providers there.